• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macros
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macros
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
Nairametrics
No Result
View All Result
Home Business News
GlaxoSmitheKline Consumer Nigeria Plc

Why GlaxoSmithKline Nigeria plans to close its Agbara plant

Emmanuel Abara Benson by Emmanuel Abara Benson
5 years ago
in Business News, Company News
Share on FacebookShare on TwitterShare on Linkedin

The management of GlaxoSmitheKline Consumer Nigeria Plc (GSK) says it plans to shut down its production facility in Agbara by the third quarter of 2021.

The plan is part of the leading pharmaceutical company’s restructuring efforts, which would see it focus on building “a more sustainable commercial business”.

More details about the move

A corporate disclosure issued to the Nigerian Stock Exchange, today, says the company’s Board of Directors approved the plan.

Reason for the planned closure – The document went further to disclose that the pharmaceutical company will transition to contract manufacturing. In other words, GSK will work with local contract manufacturers for the supply of the company’s drugs and other pharmaceutical products.

Expected outcome of the move – GSK’s restructured business model will enable it to transfer technical knowledge and build local production capacity. It will also enable the company to focus on the commercial aspect of its business, which basically involves “supporting access to GSK’s consumer health products, medicines, and vaccines.”

“Following an extensive review of its product supply operation, the Board of Directors has approved a restructuring of GSK’s current operating model to better serve the Nigerian patients and consumers. The restructuring, which will be effective in Q3 2021, involves working with local contract manufacturers for the supply of GSK’s products, where possible. This will support the building of local expertise, transfer of technical knowledge, and improve local production capacities in the country.”

No local contract manufacturer has been named

In the meantime, no local contract manufacturer has been named as a partner by the drug company. Instead, part of the statement issued to the NSE said  “the identification of a suitable third party local manufacturer will be the subject of another announcement.”

Important clarifications – The company says the restructuring will affect its commitment to global health issues in Nigeria and elsewhere. It will also continue to be listed on the Nigerian Stock Exchange.

In the meantime, the Agbara plant remains functional 

The company’s Agbara plant will remain functional until the third quarter of 2021, by which time a suitable local contract manufacturer would have been found.


Download Nairametrics App for breaking news and market intelligence.
   
Tags: GlaxoSmitheKline Consumer Nigeria PlcGSK Agbara PlantGSK Nigeria
Emmanuel Abara Benson

Emmanuel Abara Benson

Emmanuel Abara Benson is an experienced business reporter and editor. He currently edits articles at Nairametrics. Reach him via email on Emmanuel.abara@nairametrics.com and follow him on Twitter @Mr_Abara for his personal opinions.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *







NM newsletters
Glo
Kwakol
Abbey
Zenth Bank
UBA
Mega Millions

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • The Government of Mauritius is offering full scholarships to African students 
  • Quiet day for SWOOTs as Nigerian Equities ASI record N192 billion loss
  • COP28: Cross River signs agreement for rollout of EVs for mass transportation  

Follow us on social media:

Recent News

International students

The Government of Mauritius is offering full scholarships to African students 

December 7, 2023
NGX

Quiet day for SWOOTs as Nigerian Equities ASI record N192 billion loss

December 7, 2023
  • Download Nairametrics iOS App
  • Download Nairametrics Android App
  • Contact Us
  • Home
  • Markets
  • Sectors
  • Economy
  • Business News
  • Financial Literacy
  • Disclaimer
  • Ads Disclaimer

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Sectors
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Health
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macros
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
  • Login
  • Sign Up
  • Cart

© 2023 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In